Cargando…
Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial
PURPOSE: To estimate the efficacy and safety of 5 mg and 10 mg mifepristone for emergency contraception up to 144 hours after unprotected coitus. METHODS: This double-blind randomized clinical trial was carried out at Eusebio Hernandez Hospital (Havana, Cuba). A total of 2,418 women who requested em...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296957/ https://www.ncbi.nlm.nih.gov/pubmed/25624773 http://dx.doi.org/10.2147/IJWH.S65793 |
_version_ | 1782353073766662144 |
---|---|
author | Carbonell, Josep Lluis Garcia, Ramon Gonzalez, Adriana Breto, Andres Sanchez, Carlos |
author_facet | Carbonell, Josep Lluis Garcia, Ramon Gonzalez, Adriana Breto, Andres Sanchez, Carlos |
author_sort | Carbonell, Josep Lluis |
collection | PubMed |
description | PURPOSE: To estimate the efficacy and safety of 5 mg and 10 mg mifepristone for emergency contraception up to 144 hours after unprotected coitus. METHODS: This double-blind randomized clinical trial was carried out at Eusebio Hernandez Hospital (Havana, Cuba). A total of 2,418 women who requested emergency contraception after unprotected coitus received either 5 mg or 10 mg mifepristone. The variables for assessing efficacy were the pregnancies that occurred and the fraction of pregnancies that were prevented. Other variables assessed were the side effects of mifepristone, vaginal bleeding, and changes in the date of the following menstruation. RESULTS: There were 15/1,206 (1.2%) and 9/1,212 (0.7%) pregnancies in the 5 mg and 10 mg group, respectively (P=0.107). There were 88% and 93% prevented pregnancies in the 5 mg and un ≥7 days was experienced by 4.9% and 11.0% of subjects in the 5 mg and 10 mg group, respectively (P=0.001). There was a significant high failure rate for women weighing >75 kg in the 5 mg group. CONCLUSION: It would be advisable to use the 10 mg dose of mifepristone for emergency contraception as there was a trend suggesting that the failure rate of the larger dose was lower. |
format | Online Article Text |
id | pubmed-4296957 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2015 |
publisher | Dove Medical Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-42969572015-01-26 Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial Carbonell, Josep Lluis Garcia, Ramon Gonzalez, Adriana Breto, Andres Sanchez, Carlos Int J Womens Health Original Research PURPOSE: To estimate the efficacy and safety of 5 mg and 10 mg mifepristone for emergency contraception up to 144 hours after unprotected coitus. METHODS: This double-blind randomized clinical trial was carried out at Eusebio Hernandez Hospital (Havana, Cuba). A total of 2,418 women who requested emergency contraception after unprotected coitus received either 5 mg or 10 mg mifepristone. The variables for assessing efficacy were the pregnancies that occurred and the fraction of pregnancies that were prevented. Other variables assessed were the side effects of mifepristone, vaginal bleeding, and changes in the date of the following menstruation. RESULTS: There were 15/1,206 (1.2%) and 9/1,212 (0.7%) pregnancies in the 5 mg and 10 mg group, respectively (P=0.107). There were 88% and 93% prevented pregnancies in the 5 mg and un ≥7 days was experienced by 4.9% and 11.0% of subjects in the 5 mg and 10 mg group, respectively (P=0.001). There was a significant high failure rate for women weighing >75 kg in the 5 mg group. CONCLUSION: It would be advisable to use the 10 mg dose of mifepristone for emergency contraception as there was a trend suggesting that the failure rate of the larger dose was lower. Dove Medical Press 2015-01-12 /pmc/articles/PMC4296957/ /pubmed/25624773 http://dx.doi.org/10.2147/IJWH.S65793 Text en © 2015 Carbonell et al. This work is published by Dove Medical Press Limited, and licensed under Creative Commons Attribution – Non Commercial (unported, v3.0) License The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0/. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. |
spellingShingle | Original Research Carbonell, Josep Lluis Garcia, Ramon Gonzalez, Adriana Breto, Andres Sanchez, Carlos Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial |
title | Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial |
title_full | Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial |
title_fullStr | Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial |
title_full_unstemmed | Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial |
title_short | Mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial |
title_sort | mifepristone 5 mg versus 10 mg for emergency contraception: double-blind randomized clinical trial |
topic | Original Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4296957/ https://www.ncbi.nlm.nih.gov/pubmed/25624773 http://dx.doi.org/10.2147/IJWH.S65793 |
work_keys_str_mv | AT carbonelljoseplluis mifepristone5mgversus10mgforemergencycontraceptiondoubleblindrandomizedclinicaltrial AT garciaramon mifepristone5mgversus10mgforemergencycontraceptiondoubleblindrandomizedclinicaltrial AT gonzalezadriana mifepristone5mgversus10mgforemergencycontraceptiondoubleblindrandomizedclinicaltrial AT bretoandres mifepristone5mgversus10mgforemergencycontraceptiondoubleblindrandomizedclinicaltrial AT sanchezcarlos mifepristone5mgversus10mgforemergencycontraceptiondoubleblindrandomizedclinicaltrial |